Abstract
Asymptomatic small vessel disease (SVD), including white matter hyperintensities (WMHIs), periventricular hyperintensities (PVHIs), silent stroke (SS), and cerebral microbleeds (CMBs), increases the risk of stroke. There are limited studies of SVD in subjects from the Middle East and Southeast Asia (SA). All patients admitted to stroke service between 2014 and 2015 were reviewed for presence of “pre-existing” SVD. Stroke mimics with no previous history of stroke were used as controls. There were 1727 patients admitted with stroke. Analysis was done on 988 subjects (914 strokes and 74 controls) who had MRI scan done. Pre-existing SVD was seen in 642 (64.9%) patients (WMHIs 19.6%, PVHIs 33.2%, SS 51.4%, and CMBs 22%). Silent strokes were significantly more common with ischemic stroke (IS) compared to intracranial hemorrhage (ICH) (62.0 vs 34.3%, p < 0.001). CMBs were more in ICH compared to IS (42.9 vs 23.1%, p < 0.001). The risk of developing CMBs among Far Eastern (FE) patients was 1.58 times more (p = 0.07), while 1.48 times more in Arabs (AR) (p = 0.026) compared to SA after adjusting for age. The risk of developing PVHIs was significantly higher in Arab compared to SA (odds ratio (OR) 1.43; p value = 0.021). Similarly, the risk of developing WMHIs was also significantly higher in AR patients (OR 1.6; p value = 0.009) compared to SA. The majority of ethnic AR, SA, and FE populations show pre-existing SVD on MRI. The advanced changes at a young age may be related to high prevalence of untreated risk factors and possibly as yet defined genetic and environmental factors.
Similar content being viewed by others
Change history
13 January 2018
The author names “Dr. Pablo Garcia Bermejo” and “Dr. Muhammad Faisal Wadiwala” needed to be added as the 6th and 7th authors, respectively. The authors regret this error.
References
Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.
Lan KK, Li L, Schulz U, Simoni M, Chan KH, Ho SL, et al. Total small vessel disease score and the risk of recurrent stroke. Neurology. 2017;88:2260–7.
Romero JR, Preis SR, Beiser A, DeCarli C, Viswanathan A, Martinez-Ramirez S, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke. 2014;45:1492–4.
Portegies MLP, Wolters FJ, Hofman A, Ikram MK, Koudstaal PJ, Ikram MA. Prestroke vascular pathology and the risk of recurrent stroke and poststroke dementia. Stroke. 2016;47:2119–22.
Kuller LH, Longstreth WT, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke. 2004;35:1821–5.
Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Salman RA, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165–74.
Gupta A, Giambrone AE, Gialdini G, Finn C, Delgado D, Gutierrez J, et al. Silent brain infarction and the risk of future stroke. A systemic meta-analysis. Stroke. 2016;47:719–25.
Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved. Lancet Neurol. 2007;6:94–7.
O’Donnell M, Yousef S. Tracking the global burden of stroke: the need for large scale international studies. Lancet Neurol. 2009;8:306–7.
Wasay M, Khatri IA, Kaul S. Stroke in South Asian countries. Nat Rev Neurol. 2014;10:135–43.
Johnson SC, Mendis S, Mathers CD. Global variations in stroke burden and mortality: estimates from monitoring, surveillance and modelling. Lancet Neurol. 2009;8:345–54.
O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, A-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112–23.
Mehndiratta MM, Khan M, Mehndiratta P, Wasay M. Stroke in Asia: geographical variations and temporal trends. J Neurol Neurosurg Psychiatry. 2014;85:1308–12.
Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries during 1988-2013. Lancet Neurol. 2016;15:913–24.
Akhtar N, Salam A, Kamran S, Bourke P, Joseph S, Santos M, et al. Ethnic variation in acute cerebrovascular disease: analysis from the Qatar stroke registry. Eur Stroke Jour. 2016;1:231–41.
Akhtar N, Kamran S, Singh R, Cameron P, D’Souza A, Imam Y, et al. Beneficial effects of implementing stroke protocols require establishment of a geographically distinct unit. Stroke. 2015;46:3494–501.
Population Chapter 2015. Ministry of Development Planning and Statistics. http://www.mdps.gov.qa/en/Statistics1. Accessed 3 Aug 2016.
Adam HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.
Brant-Zawadzki M, Fein G, Van Dyke C, Kiernan R, Davenport L, de Groot J, et al. MR imaging of the aging brain: patchy white-matter lesions and dementia. AJNR. 1985;6:675–82.
Zimmerman RD, Fleming CA, Lee BCP, Saint-Louis LA, Deck MD. Peri ventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJR. 1986;146:443–50. AJNR .1986;7: 13–20
Fazekas F, Chawlak JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol. 1987;149:351–6.
Kakar P, Charidimou A, Werring DJ. Cerebral microbleeds: new dilemma in stroke medicine. JRSM Cardiovasc Dis. 2012;1:22.
Charidimou A, Jäger HR, Werring DJ. Cerebral microbleed detection and mapping: principles, methodological aspects and rationale in vascular dementia. Exp Gerontol. 2012;47:843–52.
Pasquini M, Bebedictus MR, Boulouis G, Rossi C, Dequatre-Ponchelle N, Cordonnier C. Incident cerebral microbleeds in a cohort of intracerebral hemorrhage. Stroke. 2016;47:689–94.
Wang Y, Liu G, Hong D, Chen F, Ji X, Cao G. White matter injury and ischemic stroke. Prog Neurobiology. 2016;141:45–60.
Kleining TJ. Associations and implications of cerebral microbleeds. J Clin Neurosci. 2013;20:919–27.
Wong T, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, et al. Cerebral white matter lesions, retinopathy and incident clinical stroke. JAMA. 2002;288:67–74.
Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB, et al. Prevention of stroke in patients with silent cerebrovascular disease. Stroke. 2017;48:e44–71.
Acknowledgments
The team is grateful to Ms. Reny Francis from the Neuroscience Institute, Hamad Medical Corporation, for providing formatting support and reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study has received IRB approval at Hamad Medical Corporation.
Conflict of Interest
The authors declare that they have no conflict of interest.
Informed Consent
For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
Akhtar, N., Salam, A., Kamran, S. et al. Pre-existing Small Vessel Disease in Patients with Acute Stroke from the Middle East, Southeast Asia, and Philippines. Transl. Stroke Res. 9, 274–282 (2018). https://doi.org/10.1007/s12975-017-0578-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-017-0578-7